Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Inflammatory breast cancer, Liquid biopsy (ctDNA), HR-positive / HER2-negative breast cancer and the tag breast.
Shares Inflammatory breast cancer, HR-positive / HER2-negative breast cancer and the tag breast.
Shares HER2-positive breast cancer, Breast cancer (all types) and the tag breast.
Shares The Royal Marsden, HR-positive / HER2-negative breast cancer and the tag breast.
Shares Nottingham Prognostic Index (NPI), and PREDICT, Invasive breast carcinoma of no special type (invasive ductal carcinoma), Nottingham grade (breast cancer grade 1, 2 and 3), The WHO classification of breast tumours, and what the 6th edition changed and the tag breast.
Shares The Breast, SOLTI Cancer Research Group, Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer, RNA sequencing & expression profiling and the tag breast.
Shares The WHO classification of breast tumours, and what the 6th edition changed, Which staging edition a breast report uses: UICC TNM 8, TNM 9 and the AJCC prognostic stage, Mastectomy, Ductal carcinoma in situ (DCIS) and the tag breast.
Shares SOLTI Cancer Research Group, Trastuzumab deruxtecan, HER2, HER2-positive breast cancer and the tag breast.
The same record for scripts and assistants; checked 2026-09-25. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.